The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine

Steffan T. Nawrocki, Yingchun Han, Valeria Visconte, Bartlomiej Przychodzen, Claudia M. Espitia, James Phillips, Faiz - Anwer, Anjali Advani, Hetty E. Carraway, Kevin R. Kelly, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew

Research output: Contribution to journalLetter

3 Scopus citations
Original languageEnglish (US)
JournalLeukemia
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Nawrocki, S. T., Han, Y., Visconte, V., Przychodzen, B., Espitia, C. M., Phillips, J., Anwer, F. ., Advani, A., Carraway, H. E., Kelly, K. R., Sekeres, M. A., Maciejewski, J. P., & Carew, J. S. (2019). The novel autophagy inhibitor ROC-325 augments the antileukemic activity of azacitidine. Leukemia. https://doi.org/10.1038/s41375-019-0529-2